3/5
04:30 pm
npce
NeuroPace to Present at the Leerink Global Healthcare Conference
Low
Report
NeuroPace to Present at the Leerink Global Healthcare Conference
3/5
07:56 am
npce
NeuroPace (NPCE) was upgraded by Cantor Fitzgerald to "strong-buy".
Low
Report
NeuroPace (NPCE) was upgraded by Cantor Fitzgerald to "strong-buy".
3/4
03:52 pm
npce
Why NeuroPace Stock Was Inching Higher on Wednesday [Yahoo! Finance]
Low
Report
Why NeuroPace Stock Was Inching Higher on Wednesday [Yahoo! Finance]
3/4
12:15 am
npce
NeuroPace Inc (NPCE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Medium
Report
NeuroPace Inc (NPCE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
3/3
09:13 pm
npce
NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/3
09:10 pm
npce
NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline [Seeking Alpha]
Medium
Report
NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline [Seeking Alpha]
3/3
06:50 pm
npce
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
Medium
Report
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
3/3
06:25 pm
npce
NeuroPace (NPCE) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
NeuroPace (NPCE) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/3
06:25 pm
npce
NeuroPace Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
NeuroPace Q4 Earnings Call Highlights [Yahoo! Finance]
3/3
04:28 pm
npce
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook [Yahoo! Finance]
High
Report
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook [Yahoo! Finance]
3/3
04:05 pm
npce
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
Low
Report
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
3/2
06:03 pm
npce
Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight [Yahoo! Finance]
Medium
Report
Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight [Yahoo! Finance]
2/24
11:33 am
npce
NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
Low
Report
NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
2/20
04:42 pm
npce
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026 [Yahoo! Finance]
Low
Report
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026 [Yahoo! Finance]
2/20
04:30 pm
npce
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
Low
Report
NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
1/27
07:19 am
npce
NeuroPace (NASDAQ:NPCE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
NeuroPace (NASDAQ:NPCE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/14
02:10 pm
npce
NeuroPace (NASDAQ:NPCE) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
NeuroPace (NASDAQ:NPCE) had its "buy" rating reaffirmed by analysts at UBS Group AG.
1/13
07:42 am
npce
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook [Yahoo! Finance]
Medium
Report
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook [Yahoo! Finance]
1/13
07:41 am
npce
NeuroPace sees Q4 revenue of about $26.6M [Seeking Alpha]
Medium
Report
NeuroPace sees Q4 revenue of about $26.6M [Seeking Alpha]
1/13
07:30 am
npce
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
Medium
Report
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
12/31
09:27 am
npce
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/31
09:00 am
npce
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/17
08:00 am
npce
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
Medium
Report
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
12/16
09:32 am
npce
NeuroPace (NASDAQ:NPCE) had its price target raised by analysts at UBS Group AG from $18.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
NeuroPace (NASDAQ:NPCE) had its price target raised by analysts at UBS Group AG from $18.00 to $22.00. They now have a "buy" rating on the stock.
12/11
04:18 am
npce
NeuroPace (NASDAQ:NPCE) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
NeuroPace (NASDAQ:NPCE) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.